On October 14, 2026, the U.S. Food and Drug Administration (FDA) formally unveiled the "Rare Disease Framework Initiative," a comprehensive…
Read More
TWiV 1290: Clinical Update with Dr. Daniel Griffin and Vincent Racaniello Focuses on Longevity, Infectious Disease Metrics, and Public Health Policy
In the latest installment of the popular weekly clinical update series on This Week in Virology (TWiV), co-hosts Dr. Daniel…
Read More
The FDA’s Pursuit of "Radical Transparency" Sparks Debate on Policy Clarity
The U.S. Food and Drug Administration’s (FDA) ambitious drive towards "radical transparency," particularly through the public release of Complete Response…
Read More
TWiV 1288: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Vaccine Policy and Ongoing Public Health Challenges
In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound concern…
Read More
Marty Makary Resigns as FDA Commissioner Amid Intensifying Administrative Pressure and Policy Conflicts
Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration, effective immediately, following weeks of escalating speculation…
Read More
ADA Conference Concludes with Groundbreaking GLP-1 Trial Results Amidst Unprecedented Protests Over Science Policy
The annual scientific sessions of the American Diabetes Association (ADA) this week served as a pivotal platform for unveiling cutting-edge…
Read More
FDA Commissioner Marty Makary Resigns Amid Pressure from Administration, Citing Policy Conflicts and Agency Instability
Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration, effective immediately, amidst a period of intense…
Read More
Marty Makary Resigns as FDA Commissioner Amidst Administration Pressure and Policy Conflicts
Marty Makary’s tenure as commissioner of the Food and Drug Administration (FDA) concluded abruptly on Tuesday with his resignation, a…
Read More
TWiV 1292: Clinical Update with Dr. Daniel Griffin Examines Public Health Decline, Vaccine Policy Shifts, and Resurgent Infectious Diseases
In a recent clinical update on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin and host Vincent Racaniello…
Read More
FDA Rejects Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Flaws Amidst Broader Policy Shifts
Moderna, a leading biotechnology company, announced on Tuesday that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation…
Read More
